Imaging of Coronary Plaques in Participants Treated With Evolocumab

NCT03570697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: Evolocumab
DRUG: Placebo
DRUG: Statin therapy

Sponsor

Amgen